Related references
Note: Only part of the references are listed.A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents
Atsuo Tanimoto et al.
EXPERIMENTAL DERMATOLOGY (2018)
Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis
M. Furue et al.
ALLERGY (2018)
Monitoring of topical corticosteroid phobia in a population of parents with children with atopic dermatitis using the TOPICOP® scale: prevalence, risk factors and the impact of therapeutic patient education
F. Gonzales et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2017)
Safety evaluation of apremilast for the treatment of psoriasis
A. Dattola et al.
EXPERT OPINION ON DRUG SAFETY (2017)
2% Crisaborole topical ointment for the treatment of mild-to-moderate atopic dermatitis
Alice C. Cheape et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2017)
Itch in Atopic Dermatitis
Makiko Kido-Nakahara et al.
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2017)
Inflammatory skin march in atopic dermatitis and psoriasis
Masutaka Furue et al.
INFLAMMATION RESEARCH (2017)
Efficacy and safety of dupilumab for the treatment of adult atopic dermatitis: A meta-analysis of randomized clinical trials
Yue Han et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology guidelines
Lawrence F. Eichenfield et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
2-Year animal carcinogenicity results for crisaborole, a novel phosphodiesterase 4 inhibitor for atopic dermatitis
Vic Ciaravino et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2017)
Tapinarof Is a Natural AhR Agonist that Resolves Skin Inflammation in Mice and Humans
Susan H. Smith et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
Andrew Blauvelt et al.
LANCET (2017)
Anti-Interleukin-31 Receptor A Antibody for Atopic Dermatitis
Thomas Ruzicka et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies
Masutaka Furue et al.
ALLERGOLOGY INTERNATIONAL (2017)
Special Considerations for Therapy of Pediatric Atopic Dermatitis
Nanette B. Silverberg et al.
DERMATOLOGIC CLINICS (2017)
The first trial of CIM331, a humanized antihuman interleukin-31 receptor A antibody, in healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomized, double-blind, placebo-controlled study
O. Nemoto et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Advances in therapeutic strategies for the treatment of pruritus
Carolyn Stull et al.
EXPERT OPINION ON PHARMACOTHERAPY (2016)
Safety, tolerability and pharmacokinetics of a novel phosphodiesterase inhibitor, E6005 ointment, in healthy volunteers and in patients with atopic dermatitis
Fuminori Ohba et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Effect of topical phosphodiesterase 4 inhibitor E6005 on Japanese children with atopic dermatitis: Results from a randomized, vehicle-controlled exploratory trial
Osamu Nemoto et al.
JOURNAL OF DERMATOLOGY (2016)
Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
R. Bissonnette et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis
Luca Bianchi et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
A new therapeutic for the treatment of moderate-to-severe plaque psoriasis: apremilast
Andrea Chiricozzi et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2016)
Crisaborole and its potential role in treating atopic dermatitis: overview of early clinical studies
L. T. Zane et al.
IMMUNOTHERAPY (2016)
Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study
Fuminori Ohba et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Management of erythematous skin lesions in bullous pemphigoid associated with atopic dermatitis
Koji Kamiya et al.
JOURNAL OF DERMATOLOGY (2016)
Various diagnostic criteria for atopic dermatitis (AD): A proposal of Reliable Estimation of Atopic Dermatitis in Childhood (REACH) criteria, a novel questionnaire-based diagnostic tool for AD
Seung-Chul Lee
JOURNAL OF DERMATOLOGY (2016)
Inhibitory effect of a histamine 4 receptor antagonist on CCL17 and CCL22 production by monocyte-derived Langerhans cells in patients with atopic dermatitis
Kyohei Miyano et al.
JOURNAL OF DERMATOLOGY (2016)
Potential preventive effects of proactive therapy on sensitization in moderate to severe childhood atopic dermatitis: A randomized, investigator-blinded, controlled study
Tatsuki Fukuie et al.
JOURNAL OF DERMATOLOGY (2016)
Levels of immunoglobulin E specific to the major food allergen and chemokine (C-C motif) ligand (CCL) 17/thymus and activation regulated chemokine and CCL22/macrophage-derived chemokine in infantile atopic dermatitis on Ishigaki Island
Hitokazu Esaki et al.
JOURNAL OF DERMATOLOGY (2016)
Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
Hidehisa Saeki et al.
JOURNAL OF DERMATOLOGY (2016)
Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults
Amy S. Paller et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2016)
ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients
A. Wollenberg et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2016)
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
E. L. Simpson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations
Kenta Horimukai et al.
ALLERGOLOGY INTERNATIONAL (2016)
A putative antipruritic mechanism of the phosphodiesterase-4 inhibitor E6005 by attenuating capsaicin-induced depolarization of C-fibre nerves
Hisashi Wakita et al.
EXPERIMENTAL DERMATOLOGY (2015)
The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis
A. Tsianakas et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
Apremilast for the treatment of psoriasis
Maria Sole Chimenti et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA) 1 TH2/TH1 cell imbalance, whereas adults acquire CLA1+ TH22/TC22 cell subsets
Tali Czarnowicki et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
Characterization of socioeconomic status of Japanese patients with atopic dermatitis showing poor medical adherence and reasons for drug discontinuation
Hiroyuki Murota et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2015)
New therapies for controlling atopic itch
Masutaka Furue et al.
JOURNAL OF DERMATOLOGY (2015)
Novel FLG null mutations in Korean patients with atopic dermatitis and comparison of the mutational spectra in Asian populations
Joonhong Park et al.
JOURNAL OF DERMATOLOGY (2015)
Microbiome and pediatric atopic dermatitis
Claire E. Powers et al.
JOURNAL OF DERMATOLOGY (2015)
Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis
Yoko Murata et al.
JOURNAL OF DERMATOLOGY (2015)
Antioxidant soybean tar Glyteer rescues T-helper-mediated downregulation of filaggrin expression via aryl hydrocarbon receptor
Kenjiro Takei et al.
JOURNAL OF DERMATOLOGY (2015)
Use of emollients in atopic dermatitis
J. P. X. Ng et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Apremilast is a selective PDE4 inhibitor with regulatory effects on innate immunity
P. H. Schafer et al.
CELLULAR SIGNALLING (2014)
Topical E6005, a novel phosphodiesterase 4 inhibitor, attenuates spontaneous itch- related responses in mice with chronic atopy-like dermatitis
Tsugunobu Andoh et al.
EXPERIMENTAL DERMATOLOGY (2014)
Application of moisturizer to neonates prevents development of atopic dermatitis
Kenta Horimukai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Effect of the phosphodiesterase 4 inhibitor E6005 on nerve growth factor elevation in irritated skin of NC/Nga mice
Naoto Ishii et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Antipruritic mechanisms of topical E6005, a phosphodiesterase 4 inhibitor: Inhibition of responses to proteinase-activated receptor 2 stimulation mediated by increase in intracellular cyclic AMP
Tsugunobu Andoh et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Safety and efficacy of topical E6005, a phosphodiesterase 4 inhibitor, in Japanese adult patients with atopic dermatitis: Results of a randomized, vehicle-controlled, multicenter clinical trial
Masutaka Furue et al.
JOURNAL OF DERMATOLOGY (2014)
Antipruritic Effect of the Topical Phosphodiesterase 4 Inhibitor E6005 Ameliorates Skin Lesions in a Mouse Atopic Dermatitis Model
Naoto Ishii et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Relieving the Pruritus of Atopic Dermatitis: A Meta-analysis
Lindsay G. Sher et al.
ACTA DERMATO-VENEREOLOGICA (2012)
Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial
R. Bissonnette et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis
Julia K. Gittler et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2012)
Mammalian Cyclic Nucleotide Phosphodiesterases: Molecular Mechanisms and Physiological Functions
Sharron H. Francis et al.
PHYSIOLOGICAL REVIEWS (2011)
Collared mice: A model to assess the effects of scratching
Satoshi Takeuchi et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2010)
Proactive therapy of atopic dermatitis - an emerging concept
A. Wollenberg et al.
ALLERGY (2009)
Effect of phosphodiesterase 4 inhibitors on NFAT-dependent cyclooxygenase-2 expression in human T lymphocytes
JL Jimenez et al.
CELLULAR SIGNALLING (2004)
The use of corticosteroids and corticosteroid phobia in atopic dermatitis
C Charman et al.
CLINICS IN DERMATOLOGY (2003)
Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis
M Furue et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Topical corticosteroid phobia in patients with atopic eczema
CR Charman et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
Share Paper
